How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Clinical Trial Supply and Logistic for Pharmaceutical Market
- By Service Type: Packaging Services, Labeling Services, Storage and Warehousing, Distribution and Logistics, Temperature Management
- By Clinical Trial Phase: Phase I, Phase II, Phase III, Phase IV
- By Product Type: Biologics, Small Molecule Drugs, Biosimilars, Vaccines, Advanced Therapy Medicinal Products (ATMPs)
- By Packaging Format: Blister Packs, Vials and Ampoules, Pre-filled Syringes, Bottles and Containers, Kits and Combination Packs
- By Temperature Requirement: Ambient, Refrigerated (2-8°C), Frozen (-20°C), Ultra-frozen (-80°C and below)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Packaging Services leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Clinical Trial Supply and Logistic for Pharmaceutical Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
Clinical Trial Phase 4
Product Type 5
Packaging Format 5
Temperature Requirement 4
Companies profiled
Catalent Inc.
PCI Pharma Services
Almac Group
Sharp Clinical Services
Kuehne + Nagel International AG
Baxter International Inc.
Marken (a UPS company)
Thermo Fisher Scientific Inc.
DPx Holdings Inc.
Vetter Pharma International GmbH
Cytel Inc.
World Courier (a part of AmerisourceBergen)
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Catalent Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →PCI Pharma Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Almac Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sharp Clinical Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Kuehne + Nagel International AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Marken (a UPS company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Thermo Fisher Scientific Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →DPx Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Vetter Pharma International GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cytel Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →World Courier (a part of AmerisourceBergen)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Biocair
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Siegfried Holding AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,335M by 2033 · 8.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Packaging Services48.5
- Labeling Services9.1
- Storage and Warehousing18.3
- Distribution and Logistics14.2
- Temperature Management9.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,727M → $3,064M · 7.4%
Europe$1,204M → $2,309M · 8.5%
Asia Pacific$1,099M → $2,407M · 10.3%
Latin America$680.4M → $1,392M · 9.4%
Middle East and Africa$523.4M → $995.2M · 8.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.832026
8.842027
8.852028
8.872029
8.872030
8.892031
8.902032
8.912033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Catalent Inc.9.1
- PCI Pharma Services21.8
- Almac Group7.4
- Sharp Clinical Services12.4
- Kuehne + Nagel International AG11.9
- Baxter International Inc.9.3
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type20.2%
Clinical Trial Phase13.7%
Product Type29.8%
Packaging Format14.8%
Temperature Requirement21.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.1
- Europe22.7
- Asia Pacific23.7
- Latin America13.7
- Middle East and Africa9.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 93 | 85 | 83 | 85 | 94 | 84 | 87 |
| PCI Pharma Services | 73 | 69 | 83 | 75 | 84 | 91 | 79 |
| Almac Group | 75 | 84 | 76 | 72 | 64 | 65 | 73 |
| Sharp Clinical Services | 78 | 59 | 73 | 69 | 59 | 60 | 66 |
| Kuehne + Nagel International AG | 74 | 73 | 66 | 70 | 66 | 72 | 70 |
| Baxter International Inc. | 59 | 51 | 51 | 57 | 70 | 62 | 58 |
| Marken (a UPS company) | 64 | 56 | 62 | 61 | 65 | 59 | 61 |
| Thermo Fisher Scientific Inc. | 49 | 55 | 45 | 42 | 48 | 54 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Catalent Inc.
- PCI Pharma Services
- Almac Group
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Catalent Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| PCI Pharma Services | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Almac Group | ◐ | ◐ | ◐ | ✓ | ◐ | − |
| Sharp Clinical Services | ◐ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Kuehne + Nagel International AG | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Baxter International Inc. | ◐ | − | − | ◐ | ◐ | ◐ |
| Marken (a UPS company) | − | − | − | ◐ | ✓ | ◐ |
| Thermo Fisher Scientific Inc. | − | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Catalent Inc.87
2PCI Pharma Services79
3Almac Group73
4Kuehne + Nagel International AG70
5Sharp Clinical Services66
6Marken (a UPS company)61
7Baxter International Inc.58
8Thermo Fisher Scientific Inc.49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Catalent Inc.PCI Pharma Services
Challenger2
Strong scale, closing on the leaders.
Almac GroupKuehne + Nagel International AG
Contender3
Focused players with pockets of strength.
Sharp Clinical ServicesBaxter International Inc.Marken (a UPS company)
Niche1
Specialists in a single segment or region.
Thermo Fisher Scientific Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Clinical Trial Supply and Logistic for Pharmaceutical Market — a $207M beachhead inside a $3.48B market.
Beachhead (SOM)$207Mobtainable near-term
Serviceable (SAM)$1.39Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Packaging Services
Best fit — highest urgency & budget in Service Type.
Economic buyer77 fit
Labeling Services
Strong fit — clear ROI and a fast path to value.
End user67 fit
Storage and Warehousing
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Clinical Trial Phase & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Product Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Clinical Trial Supply and Logistic for Pharmaceutical Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified24%
Evaluation13%
Closed-won5%
$10.0KCAC
$57KLTV
5.7:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Clinical Trial Supply and Logistic for Pharmaceutical Market is a high-growth opportunity — $10.9B by 2033, compounding at 10.2%.
TAM · 2025$4.99Btoday
TAM · 2033$10.9Bforecast
CAGR10.2%2027–2033
Cumulative$68.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.9BTotal addressable market
SAM$4.46BServiceable available market
SOM$934MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.2% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.9BLarge & growingTAM by 2033 at 10.2% CAGR
$4.46BServiceable nowreachable with today’s model
$934MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.48BBear6.6% CAGR
$10.9BBase10.2% CAGR
$13.9BBull13.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Clinical Trial Phase optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Clinical Trial Supply and Logistic for Pharmaceutical Market — a $7.28B market by 2033. Plan: grow share from 6.1% to 11.5%.
Market size · 2033$7.28Btotal addressable
Market CAGR5.0%2027–2033
Target share11.5%from 6.1% today
Revenue ambition$838Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.1% | 11.5% | At risk |
| Revenue | $457M | $838M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 32.0% | 42.6% | On track |
| Customer retention | 89.7% | 92.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Clinical Trial Phase capability
A defensible second engine — invest in Clinical Trial Phase to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Clinical Trial Phase
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $122M capacity & capability investment
- Greenlight bolt-on M&A in Clinical Trial Phase
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Clinical Trial Supply and Logistic for Pharmaceutical Market conversation — a $4.45B market you can size, segment and defend in minutes.
Market size · 2033$4.45Btotal opportunity
Growth11.4%CAGR to 2033
Addressable buyers1,105+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 4 mopayback period
$48K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Catalent Inc.PCI Pharma ServicesAlmac GroupSharp Clinical ServicesKuehne + Nagel International AGBaxter International Inc.Marken (a UPS company)Thermo Fisher Scientific Inc.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Clinical Trial Supply and Logistic for Pharmaceutical Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Clinical Trial Supply and Logistic for Pharmaceutical Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Clinical Trails Management Systems Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reporte-Prescription Systems Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View report5G for Medical Market
Market size, share, segmentation and regional forecast.
$484M market · 2025 base year
View reportMobile Sports and Fitness Ecosystems Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportAged Care Services Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportPrenatal Screening Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportAutomated Patient Appointment Reminder Software Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportMental Health Software Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportMedical Enterprise Data Storage Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportSingle Nucleotide Polymorphism (SNP) Genotyping Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportAutomated Insulin Delivery Systems Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportAlternative Drug Delivery Systems Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.